头孢哌酮、头孢噻肟、拉氧头孢和羧苄西林与妥布霉素联合应用对铜绿假单胞菌的比较协同活性。
Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
作者信息
Mintz L, Drew W L
出版信息
Antimicrob Agents Chemother. 1981 Feb;19(2):332-4. doi: 10.1128/AAC.19.2.332.
Abstract
A broth dilution checkerboard synergy assay was used to assess the activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, in combination with tobramycin, against 38 strains of Pseudomonas aeruginosa. Synergy occurred significantly more often (P less than 0.001) when tobramycin was combined with cefotaxime (63%) than when it was combined with carbenicillin (26%), cefoperazone (21%), or moxalactam (18%). Of the 25 synergistically inhibited strains, the combination cefotaxime-tobramycin was synergistic against 24 and was the only synergistic combination against 10. Of six strains initially resistant to cefotaxime, five were susceptible to this agent (minimum inhibitory concentration, less than or equal to 32 micrograms/ml) when it was combined with tobramycin. Clinical trials are needed to determine the therapeutic efficacy of cefotaxime-aminoglycoside combinations in the treatment of serious Pseudomonas infections.
摘要
采用肉汤稀释棋盘协同试验，评估头孢哌酮、头孢噻肟、拉氧头孢和羧苄西林分别与妥布霉素联合对38株铜绿假单胞菌的活性。与羧苄西林（26%）、头孢哌酮（21%）或拉氧头孢（18%）联合相比，妥布霉素与头孢噻肟联合时协同作用显著更常见（P<0.001）（63%）。在25株被协同抑制的菌株中，头孢噻肟-妥布霉素组合对24株具有协同作用，且是10株菌株唯一的协同组合。最初对头孢噻肟耐药的6株菌株中，5株在与妥布霉素联合时对该药物敏感（最低抑菌浓度≤32μg/ml）。需要进行临床试验以确定头孢噻肟-氨基糖苷类药物联合治疗严重铜绿假单胞菌感染的疗效。
相似文献
1
Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.头孢哌酮、头孢噻肟、拉氧头孢和羧苄西林与妥布霉素联合应用对铜绿假单胞菌的比较协同活性。
Antimicrob Agents Chemother. 1981 Feb;19(2):332-4. doi: 10.1128/AAC.19.2.332.
2
Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillin.
J Antimicrob Chemother. 1981 Sep;8(3):205-11. doi: 10.1093/jac/8.3.205.
3
Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.头孢哌酮、头孢噻肟、头孢磺啶、头孢他啶、拉氧头孢和头孢曲松对铜绿假单胞菌的β-内酰胺酶稳定性及体外活性比较。
J Antimicrob Chemother. 1981 Oct;8(4):323-31. doi: 10.1093/jac/8.4.323.
4
Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.氨基糖苷类药物与β-内酰胺类药物联合用于抗革兰氏阴性菌。体外协同作用及化学相互作用的评估。
Am J Med. 1986 Jun 30;80(6B):126-37. doi: 10.1016/0002-9343(86)90490-0.
5
Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli.头孢噻肟与选定的β-内酰胺类抗生素对流感嗜血杆菌和需氧革兰氏阴性杆菌的比较活性。
Rev Infect Dis. 1982 Sep-Oct;4 Suppl:S401-5. doi: 10.1093/clinids/4.supplement_2.s401.
6
A study of cefoperazone alone and in combination with tobramycin against Pseudomonas aeruginosa.一项关于头孢哌酮单独使用及与妥布霉素联合使用对铜绿假单胞菌作用的研究。
Clin Ther. 1980;3(Spec Issue):134-8.
7
Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.头孢哌酮对耐羧苄西林铜绿假单胞菌分离株的作用：与其他新型头孢菌素及N-甲酰亚胺硫霉素的比较
J Antimicrob Chemother. 1983 Oct;12(4):337-45. doi: 10.1093/jac/12.4.337.
8
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.接种量对头孢哌酮、头孢噻肟、拉氧头孢、哌拉西林及N-甲酰亚胺硫霉素（MK0787）抗铜绿假单胞菌活性的影响。
Antimicrob Agents Chemother. 1980 Dec;18(6):893-6. doi: 10.1128/AAC.18.6.893.
9
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.莫西拉酸（LY127935），一种新型半合成1-氧杂-β-内酰胺抗生素，具有显著的抗菌活性：与头孢孟多和妥布霉素的体外比较。
Antimicrob Agents Chemother. 1980 Apr;17(4):750-6. doi: 10.1128/AAC.17.4.750.
10
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.头孢噻肟、头孢磺啶、阿洛西林、美洛西林与氨基糖苷类药物联合应用对耐羧苄西林或敏感铜绿假单胞菌的协同作用。
J Antimicrob Chemother. 1980 Jul;6(4):471-7. doi: 10.1093/jac/6.4.471.
引用本文的文献
1
Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporins.阿米卡星联合用药对中度敏感于第三代头孢菌素的肠杆菌科细菌的抗菌活性。
Antimicrob Agents Chemother. 1982 Dec;22(6):985-9. doi: 10.1128/AAC.22.6.985.
2
Comparative in vitro activities of beta-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli.β-内酰胺类与妥布霉素联合用药对铜绿假单胞菌和多重耐药革兰氏阴性肠道杆菌的体外比较活性
Antimicrob Agents Chemother. 1982 Jun;21(6):1003-6. doi: 10.1128/AAC.21.6.1003.
3
In vitro activity of U-63196E, a new cephalosporin, against clinical bacterial isolates.新型头孢菌素U-63196E对临床分离细菌的体外活性
Antimicrob Agents Chemother. 1984 Apr;25(4):401-4. doi: 10.1128/AAC.25.4.401.
4
In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa.氨基糖苷类药物与新型β-内酰胺类药物对多重耐药铜绿假单胞菌的体外协同活性
Antimicrob Agents Chemother. 1984 Apr;25(4):534-6. doi: 10.1128/AAC.25.4.534.
5
Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.拉氧头孢。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1983 Oct;26(4):279-333. doi: 10.2165/00003495-198326040-00001.
6
Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.头孢噻肟：抗菌活性、药理特性及治疗用途综述
Drugs. 1983 Mar;25(3):223-89. doi: 10.2165/00003495-198325030-00001.
7
Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolates.阿洛西林-头孢噻肟与阿洛西林-妥布霉素联合用药对血液及多重耐药菌分离株的体外比较活性
Antimicrob Agents Chemother. 1982 Jul;22(1):167-9. doi: 10.1128/AAC.22.1.167.
8
Bactericidal and synergistic activity of moxalactam alone and in combination with gentamicin against Pseudomonas aeruginosa.羟羧氧酰胺菌素单独及与庆大霉素联合对铜绿假单胞菌的杀菌及协同活性。
Antimicrob Agents Chemother. 1983 Jan;23(1):179-81. doi: 10.1128/AAC.23.1.179.
9
Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.N-甲脒硫霉素和羟羧氧酰胺菌素对非发酵需氧革兰氏阴性杆菌的体外比较活性
Antimicrob Agents Chemother. 1982 Apr;21(4):673-5. doi: 10.1128/AAC.21.4.673.
10
In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.哌拉西林、替卡西林和美洛西林单独及与氨基糖苷类联合应用对铜绿假单胞菌的体外活性。
Antimicrob Agents Chemother. 1986 Jul;30(1):25-30. doi: 10.1128/AAC.30.1.25.
本文引用的文献
1
Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.头孢噻肟：体外活性及纸片药敏试验的初步解释标准
Antimicrob Agents Chemother. 1980 Jul;18(1):88-93. doi: 10.1128/AAC.18.1.88.
2
Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia.对患有癌症和粒细胞减少症的发热患者采用羧苄青霉素和庆大霉素进行经验性治疗。
N Engl J Med. 1971 May 13;284(19):1061-5. doi: 10.1056/NEJM197105132841904.
3
The use of combinations of antimicrobial drugs.抗菌药物联合使用
Annu Rev Pharmacol. 1968;8:151-70. doi: 10.1146/annurev.pa.08.040168.001055.
4
Antibiotic synergy in experimental infection with Pseudomonas. II. The effect of carbenicillin, cephalothin, or cephanone combined with tobramycin or gentamicin.铜绿假单胞菌实验性感染中的抗生素协同作用。II. 羧苄西林、头孢噻吩或头孢乙腈与妥布霉素或庆大霉素联合使用的效果。
J Infect Dis. 1974 Feb;129(2):124-33. doi: 10.1093/infdis/129.2.124.
5
Clinical significance of in vitro synergism between antibiotics in gram-negative infections.革兰氏阴性菌感染中抗生素体外协同作用的临床意义。
Antimicrob Agents Chemother. 1972 Dec;2(6):470-5. doi: 10.1128/AAC.2.6.470.
6
Experimental endocarditis due to Pseudomonas aeruginosa. II. Therapy with carbenicillin and gentamicin.铜绿假单胞菌所致实验性心内膜炎。II. 羧苄西林与庆大霉素治疗
J Infect Dis. 1977 Sep;136(3):327-35. doi: 10.1093/infdis/136.3.327.
7
Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats.羧苄青霉素与庆大霉素对中性粒细胞减少大鼠实验性假单胞菌血症的协同活性。
Antimicrob Agents Chemother. 1976 Oct;10(4):646-51. doi: 10.1128/AAC.10.4.646.
8
Antimicrobial synergism--an elusive concept.抗菌协同作用——一个难以捉摸的概念。
J Infect Dis. 1979 Oct;140(4):639-41. doi: 10.1093/infdis/140.4.639.
9
Comparison of techniques for measurement of in vitro antibiotic synergism.体外抗生素协同作用测量技术的比较。
J Infect Dis. 1979 Oct;140(4):629-33. doi: 10.1093/infdis/140.4.629.
10
Significance of antimicrobial synergism for the outcome of gram negative sepsis.
Am J Med Sci. 1977 Mar-Apr;273(2):157-67. doi: 10.1097/00000441-197703000-00005.
Zotero 插件